The Copper Chelator Tetrathiomolybdate Regressed Bleomycin-Induced Pulmonary Fibrosis in Mice, by Reducing Lysyl Oxidase Expressions

Biological Trace Element Research

Volumn 162, Issue 1-3, 2014, Pages 189-199

  Ovet, Hale ^a   Oztay, Fusun ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

Lysyl oxidases; MMP2; MMP8; Pulmonary fibrosis; Tetrathiomolybdate; TIMP1

Indexed keywords

BLEOMYCIN; CHELATING AGENT; COLLAGEN TYPE 1; COPPER; GELATINASE A; LYSYL OXIDASE LIKE 1; LYSYL OXIDASE LIKE 2; NEUTROPHIL COLLAGENASE; PROTEIN LYSINE 6 OXIDASE; TETRATHIOMOLYBDIC ACID; TISSUE INHIBITOR OF METALLOPROTEINASE 1; UNCLASSIFIED DRUG; MOLYBDENUM;

ADULT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; LUNG FIBROSIS; MALE; NONHUMAN; PROTEIN EXPRESSION; REMISSION; WESTERN BLOTTING; ANIMAL; C57BL MOUSE; CHEMICALLY INDUCED; ENZYMOLOGY; METABOLISM; MOUSE; PULMONARY FIBROSIS;

MUS;

ANIMALS; BLEOMYCIN; CHELATING AGENTS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 8; MICE; MICE, INBRED C57BL; MOLYBDENUM; PROTEIN-LYSINE 6-OXIDASE; PULMONARY FIBROSIS;

EID: 84912139086     PISSN: 01634984     EISSN: 15590720     Source Type: Journal    
DOI: 10.1007/s12011-014-0142-1     Document Type: Article

References (35)

1. Pardo A, Selman M (2002) Idiopathic pulmonary fibrosis: new insights in its pathogenesis. Int J Biochem Cell Biol 34(12):1534–1538
2. Noble PW, Albera C, Bradford WZ, Costabel U, Glassberg MK, Kardatzke D, King TE Jr, Lancaster L, Sahn SA, Szwarcberg J, Valeyre D, du Bois RM; CAPACITY Study Group (2011) Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials. Lancet 377(9779):1760–1769
3. Siegel RC (1974) Biosynthesis of collagen crosslinks: increased activity of purified lysyl oxidase with reconstituted collagen fibrils. Proc Natl Acad Sci USA71(12):4826–4830
4. Barry-Hamilton V, Spangler R, Marshall D, McCauley S, Rodriguez HM, Oyasu M, Mikels A, Vaysberg M, Ghermazien H, Wai C, Garcia CA, Velayo AC, Jorgensen B, Biermann D, Tsai D, Green J, Zaffryar-Eilot S, Holzer A, Ogg S, Thai D, Neufeld G, Van Vlasselaer P, Smith V (2010) Allosteric inhibition of lysyl oxidase-like-2 impedes the development of a pathologic microenvironment. Nat Med 16(9):1009–1017
5. Blaisdell RJ, Giri SN (1995) Mechanism of antifibrotic effect of taurine and niacin in the multidose bleomycin-hamster model of lung fibrosis: inhibition of lysyl oxidase and collagenase. J Biochem Toxicol 10(4):203–210
6. Cox TR, Bird D, Baker AM, Barker HE, Ho MW-Y, Lang G, Erler JT (2013) LOX-mediated collagen crosslinking is responsible for fibrosis-enhanced metastasis. Cancer Res 73(6):1721–1732
7. Ledwozyw A (1995) The effect of beta-aminopropionitrile on bleomycin-induced lung injury in rats. Acta Physiol Hung 83(1):91–99
8. Brewer GJ, Dick R, Ullenbruch MR, Jin H, Phan SH (2004) Inhibition of key cytokines by tetrathiomolybdate in the bleomycin model of pulmonary fibrosis. J Inorg Biochem 98(12):2160–2167
9. Song Z, Barve S, Zhang J, Chen T, Liu M, Arteel GE, Brewer GJ, McClain CJ (2008) Tetrathiomolybdate protects against bile duct ligation-induced cholestatic liver injury and fibrosis. J Pharmacol Exp Ther 325(2):409–416
10. Hübner RH, Gitter W, El Mokhtari NE, Mathiak M, Both M, Bolte H, Freitag-Wolf S, Bewig B (2008) Standardized quantification of pulmonary fibrosis in histological samples. Biotechniques 44(4):507–511
11. Kayalar O, Oztay F (2014) Retinoic acid induced repair in the lung of adult hyperoxic mice, reducing transforming growth factor-β1 (TGF-β1) mediated abnormal alterations. Acta Histochem 116(5):810–819
12. Geismar LS, Hennessey S, Reiser KM, Last JA (1986) D-penicillamine prevents collagen accumulation in lungs of rats given bleomycin. Chest 89(3):153S–154S
13. Selman M, Carrillo G, Salas J, Padilla RP, Pérez-Chavira R, Sansores R, Chapela R (1998) Colchicine, D-penicillamine and prednisone in the treatment of idiopathic pulmonary fibrosis: a controlled clinical trial. Chest 114(2):507–512
14. Brewer GJ, Ullenbruch MR, Dick R, Olivarez L, Phan SH (2013) Tetrathiomolybdate therapy protects against bleomycin-induced pulmonary fibrosis in mice. J Lab Clin Med 141(3):210–216
15. Hou G, Dick R, Brewer GJ (2009) Improvement in dissolution of liver fibrosis in an animal model by tetrathiomolybdate. Exp Biol Med (Maywood) 234(6):662–665
16. Wei H, Zhang WJ, Leboeuf R, Frei B (2014) Copper induces—and copper chelation by tetrathiomolybdate inhibits—endothelial activation in vitro. Redox Rep 19(1):40–48
17. Calderwood CJ, Jones MG, Hoile L, Havelock T, Maher TM, O′Reilly KMA, Davies DE (2012) Secreted lysyl oxidase is elevated in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis. Thorax 67:A111
18. Li S, Yang X, Li W, Li J, Su X, Chen L, Yan G (2012) N-acetylcysteine downregulation of lysyl oxidase activity alleviating bleomycin-induced pulmonary fibrosis in rats. Respiration 84(6):509–517
19. López B, González A, Hermida N, Valencia F, de Teresa E, Díez J (2010) Role of lysyl oxidase in myocardial fibrosis: from basic science to clinical aspects. Am J Physiol Heart Circ Physiol 299(1):H1–H9
20. Giampuzzi M, Oleggini R, Di Donato A (2003) Demonstration of in vitro interaction between tumor suppressor lysyl oxidase and histones H1 and H2: definition of the regions involved. Biochim Biophys Acta 1647(1–2):245–251
21. Giampuzzi M, Botti G, Di Duca M, Arata L, Ghiggeri G, Gusmano R, Ravazzolo R, Di Donato A (2000) Lysyl oxidase activates the transcription activity of human collagene III promoter. Possible involvement of Ku antigen. J Biol Chem 275(46):36341–36349
22. Yılmaz O, Oztay F (2013) The effects of tyrosine kinase inhibitors on myofibroblast activation in mice lung with fibrosis: therapeutic approach. The 2nd International Congress of the Molecular Biology Association of Turkey, p77, Istanbul-Turkey
23. González GE, Rhaleb NE, Nakagawa P, Liao TD, Liu Y, Leung P, Dai X, Yang XP, Carretero OA (2014) N-acetyl-seryl-aspartyl-lysyl-proline reduces cardiac collagen cross-linking and inflammation in angiotensin II-induced hypertensive rats. Clin Sci (Lond) 126(1):85–94
24. Rafii R, Juarez MM, Albertson TE, Chan AL (2013) A review of current and novel therapies for idiopathic pulmonary fibrosis. J Thorac Dis 5(1):48–73
25. Cai Y, Zhu L, Zhang F, Niu G, Lee S, Kimura S, Chen X (2013) Noninvasive monitoring of pulmonary fibrosis by targeting matrix metalloproteinases (MMPs). Mol Pharm 10(6):2237–2247
26. Selman M, Ruiz V, Cabrera S, Segura L, Ramírez R, Barrios R, Pardo A (2000) TIMP-1, -2, -3, and -4 in idiopathic pulmonary fibrosis. A prevailing nondegradative lung microenvironment? Am J Physiol Lung Cell Mol Physiol 279(3):L562–L574
27. Ruiz V, Ordóñez RM, Berumen J, Ramírez R, Uhal B, Becerril C, Pardo A, Selman M (2003) Unbalanced collagenases/TIMP-1 expression and epithelial apoptosis in experimental lung fibrosis. Am J Physiol Lung Cell Mol Physiol 285(5):L1026–L1036
28. Kumar P, Yadav A, Patel SN, Islam M, Pan Q, Merajver SD, Teknos TN (2010) Tetrathiomolybdate inhibits head and neck cancer metastasis by decreasing tumor cell motility, invasiveness and by promoting tumor cell anoikis. Mol Cancer 9:206
29. García-de-Alba C, Becerril C, Ruiz V, González Y, Reyes S, García-Alvarez J, Selman M, Pardo A (2010) Expression of matrix metalloproteases by fibrocytes: possible role in migration and homing. Am J Respir Crit Care Med 182(9):1144–1152
30. Gutiérrez-Fernández A, Inada M, Balbín M, Fueyo A, Pitiot AS, Astudillo A, Hirose K, Hirata M, Shapiro SD, Noël A, Werb Z, Krane SM, López-Otín C, Puente XS (2007) Increased inflammation delays wound healing in mice deficient in collagenase-2 (MMP-8). FASEB J 21(10):2580–2591
31. García-Prieto E, González-López A, Cabrera S, Astudillo A, Gutiérrez-Fernández A, Fanjul-Fernandez M, Batalla-Solís E, Puente XS, Fueyo A, López-Otín C, Albaiceta GM (2010) Resistance to bleomycin-induced lung fibrosis in MMP-8 deficient mice is mediated by interleukin-10. PLoS One 5(10):e13242. doi:10.1371/journal.pone.0013242
32. Craig VJ, Quintero PA, Fyfe SE, Patel AS, Knolle MD, Kobzik L, Owen CA (2013) Profibrotic activities for matrix metalloproteinase-8 during bleomycin-mediated lung injury. J Immunol 190(8):4283–4296
33. Nkyimbeng T, Ruppert C, Shiomi T, Dahal B, Lang G, Seeger W, Okada Y, D′Armiento J, Gunther A (2013) Pivotal role of matrix metalloproteinase 13 in extracellular matrix turnover in idiopathic pulmonary fibrosis. PLoS One8 (9):e73279. doi:10.1371/journal.pone.0073279
34. Madtes DK, Elston AL, Kaback LA, Clark JG (2001) Selective induction of tissue inhibitor of metalloproteinase-1 in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 24(5):599–607
35. Ortiz LA, Lasky J, Gozal E, Ruiz V, Lungarella G, Cavarra E, Brody AR, Friedman M, Pardo A, Selman M (2001) Tumor necrosis factor receptor deficiency alters matrix metalloproteinase 13/tissue inhibitor of metalloproteinase 1 expression in murine silicosis. Am J Respir Crit Care Med 163(1):244–252